12:00 AM
Apr 01, 2013
 |  BC Week In Review  |  Company News  |  Deals

Life Technologies, Medicyte deal

Medicyte acquired non-exclusive, worldwide rights to Life Technologies' Lentiviral vector technology for use in developing and...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >